Skip to content
Home/Companies/Biotech/Pepkon

Pepkon

Biotech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Pepkon?

Pepkon is currently owned by Aloe Private Equity through Aloe Environment Fund III (2014 vintage), since 2019.

Hand-verified · updated 2026-04-21

Aloe Private Equity
Investor
Aloe Private Equity
Aloe Environment Fund III · 2014 · Growth

Key facts

HQFrance
SectorBiotech

More from Aloe Environment Fund III

Other portfolio companies in the same fund.

DeepLife
Active
BiotechFrance· 2024
WhiteLab Genomics
WhiteLab Genomics
Active
BiotechFrance· 2020

More Aloe Private Equity portfolio companies

From the same investor, across funds.

DiogenX
Active
O-Kidia
Active
Austral DX
Austral DX
Active
MedTechFrance· 2025
EVerZom
Active
BiotechFrance· 2025
Biomemory
Active
TMTFrance· 2024
Polygon
Polygon
Active
BiotechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Pepkon

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Pepkon?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Pepkon.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue